MARC COAN: Open Payments
NPI 1174516330 · TOCCOA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 48 payments from 17 companies in 2025. Trend: 2023 $1,771 · 2024 $1,194 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $311 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| ABBVIE INC. | 4 | $64 |
| Eisai Inc. | 2 | $63 |
| PFIZER INC. | 4 | $61 |
| Indivior Inc. | 4 | $60 |
| Novo Nordisk Inc | 3 | $59 |
| Calliditas Therapeutics US Inc. | 1 | $36 |
Products named: EVENITY, Kerendia, JARDIANCE, FARXIGA, Leqembi, SUBLOCADE, ELIQUIS, Ozempic.
Industry payments across GA — which companies pay providers there.
